Newsletters
- All
- AMR Action Fund
- Can you help?
- CARB-X
- CDC
- FDA
- Government Action
- Jobs
- Meetings
- PK & PK-PD
- Push/Pull
- R&D Insight
- RFPs
- Something Different
- Summaries
- Wellcome Trust
- WHO
- Wonkish
- All
- AMR Action Fund
- Can you help?
- CARB-X
- CDC
- FDA
- Government Action
- Jobs
- Meetings
- PK & PK-PD
- Push/Pull
- R&D Insight
- RFPs
- Something Different
- Summaries
- Wellcome Trust
- WHO
- Wonkish
WHO consultancy to support AMR-related messaging / 2 Mar 2020 deadline!
Dear All, WHO has just posted a job opening for a consultant in Geneva to help with spreading the word ...
Read More >
Chemical vs. drugs (Part 2): How do you discriminate? / More on halicin
This newsletter is part of a series — here are the links to Part 1, (this one is Part 2), Part ...
Read More >
Chemicals vs. drugs (Part 1): The end of bacitracin / the buzz around halicin
This newsletter is the first of a series — here are the links to Part 2, Part 3, Part 4, and ...
Read More >
Language matters: CRE vs. CPE; SDD vs. I; and MDR, XDR, PDR, UDR vs. DTR
Note: See also these related newsletters: 13 Jan 2019 (link) on DTR as part of the language of resistance and ...
Read More >
Novel Biology, Novel Utility, & the Illusion of Skill: What to develop? What to reward?
Dear All (wonk-ish note alert and also with particular thanks as always to Kevin Outterson for helping to refine this ...
Read More >
FDA workshop: Animal models to support antibacterial development (5 Mar 2020)
Dear All (moderately long note alert; be sure to note the new list of funding opportunities just below my signature), ...
Read More >
Jobs x 2: Singapore (Clinical Research Network Director) and WHO (home-based consultant)
Dear All, Two fascinating job opportunities have appeared. Even if you’re not looking for a job, the job descriptions tell ...
Read More >
Mandatory reading: Alan Carr’s Jan 2020 Antibacterial and Antifungal market review
Dear All, Alan Carr has just released his Jan 2020 review of the antibacterial and antifungal market (link). For those ...
Read More >
News from Davos 2020: Some positive signs, but overall a fragile antibiotic market at a tipping point
Dear All (and heads-up for a rather lengthy and wonkish note … settle in for the details), Last week saw ...
Read More >
New economic models for antibiotics: Are we there yet? No, but we ARE on the road
Dear All, The Duke-Margolis team hosted an excellent full-day workshop on 16 Jan 2020. Entitled “Exploring Opportunities to Reform Antimicrobial ...
Read More >
WHO 2019 Review of the Preclinical and Clinical Antibacterial Pipeline
(15 Apr 2021 update: WHO have today released a 2020 update to the report discussed in this newsletter.) Dear All, ...
Read More >
CC4CARB solicitation is out (16 Mar 2020 deadline) / Superb WSJ podcast on antibiotic economics
Dear All, I wrote on 3 Jan 2020 (link) about the NIAID contract intended to establish an innovative Chemistry Center ...
Read More >
Japan’s antibacterial R&D landscape / Japan calls for Pull incentives
Dear All: Late last year, I had the opportunity to hear a presentation on antibiotic R&D in Japan by Norio ...
Read More >
Melinta, Part 2 / Bankruptcy is not the end / Post-approval costs for an antibiotic
Dear All, I realized after sending the note about Melinta’s bankruptcy that I’d failed to be clear on what comes next ...
Read More >
NIAID/DMID seeks contract proposals for AMR / 9 Apr 2020 deadline
Dear All, As part of a NIAID Omnibus Broad Agency Announcement (BAA) posted on 31 Dec 2019, NIAID’s Division of ...
Read More >
Melinta goes bankrupt / Never let a good crisis go to waste
Dear All (long-ish, wonk-ish note alert … lots of details to absorb): This newsletter has a followup here. Sadly, Melinta ...
Read More >
NIAID to fund a Chemistry Center for Combating Antibiotic-Resistant Bacteria (CC4CARB)
Dear All, Warm up your chemistry set! NIAID has just released a pre-solicitation notice of their intent to request applications ...
Read More >
Two research calls: FDA (rabbit VAP models) and JPIAMR (aquatic pollutants)
Dear All, Two important new research calls are now out. First, FDA is offering research funding of up to $1m to ...
Read More >
2020 US Federal Funding Bill boosts support for AMR
Dear All, On Friday, 20 Dec 2020, legislation was signed to fund the US government through Sep 2020. Relevant to ...
Read More >
WHO Collaborating Centres for AMR: A rapidly growing group!
Dear All, I recently learned about the designation of Stanford as a WHO Collaborating Centre (WHOCC) for AMR and Stewardship. ...
Read More >
